Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study

Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study

Objective: Non-alcoholic fatty liver disease (NAFLD) is an established risk factor for diabetes, cardiovascular disease, antiviral treatment resistance, and progression of chronic hepatitis C virus (HCV) infection to fibrosis. Apolipoprotein-B 100 (ApoB-100) is a dyslipidemia marker and steatosis pr...

Full description

Bibliographic Details
Main Authors: Ming-Shyan Lin, Su-Er Guo, Huang-Shen Lin, Jen-Te Hsu, Yu-Sheng Lin, Tsai-Hui Lin, Tung-Jung Huang, Mei-Yen Chen, Chang-Min Chung
Format: Article
Language:English
Published: Karger Publishers 2016-04-01
Series:Obesity Facts
Subjects:
Hepatitis C virus
Apolipoprotein-B
Non-alcoholic fatty liver disease
Online Access:http://www.karger.com/Article/FullText/443692

Similar Items

Similar Items